Ledger.Open graph →
SEC Form D · filed February 13, 2024

NEURONA THERAPEUTICS, INC

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Micah Kinsler · Suite 101, AZDirectorLeo R. Guthart · South San Francisco, CADirectorJohnathan L. Manning · Savannah, GAExecMoshe Lifschitz · Englewood, NJDirectorTim Kutzkey · South San Francisco, CADirectorRay Kelleher · South San Francisco, CADirectorErica Whitaker · South San Francisco, CADirectorRobert Tjian · South San Francisco, CADirectorCatherine Sohn · South San Francisco, CADirectorSabrina Hahn · Alpine, NJDirectorJoel Cooperman · New York, NYDirectorCory Nicholas · South San Francisco, CAExec · Director · PromoterAlger A. St-Jean · Toronto, Ontario, CanadaDirectorErica Whitaker · South San Francisco, CADirectorRay Kelleher · South San Francisco, CADirectorMinyoung Sohn · Denver, COExec · Director · PromoterBrad Margus · South San Francisco, CADirectorDhivya Venkat · London, United KingdomDirectorAlan Badey · New York, NYExec · Director · PromoterJames Stutz · South San Francisco, CAExecWilliam R. Woo · New York, NYDirectorJames Stutz · South San Francisco, CAExecJeffrey F. O'Donnell Sr · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗